Corneal Ulcers - Pipeline Review, H2 2015

Publisher Name :
Date: 09-Dec-2015
No. of pages: 39
Inquire Before Buying

Global Markets Direct's, ‘Corneal Ulcers - Pipeline Review, H2 2015', provides an overview of the Corneal Ulcers's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Corneal Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Corneal Ulcers and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Corneal Ulcers

  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved in the therapeutics development for Corneal Ulcers and enlists all their major and minor projects

  • The report summarizes all the dormant and discontinued pipeline projects

  • A review of the Corneal Ulcers products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • A detailed assessment of monotherapy and combination therapy pipeline projects

  • Coverage of the Corneal Ulcers pipeline on the basis of target, MoA, route of administration and molecule type

  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Identify and understand important and diverse types of therapeutics under development for Corneal Ulcers

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Devise corrective measures for pipeline projects by understanding Corneal Ulcers pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Corneal Ulcers - Pipeline Review, H2 2015

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Corneal Ulcers Overview 6
Therapeutics Development 7
Pipeline Products for Corneal Ulcers - Overview 7
Pipeline Products for Corneal Ulcers - Comparative Analysis 8
Corneal Ulcers - Therapeutics under Development by Companies 9
Corneal Ulcers - Therapeutics under Investigation by Universities/Institutes 10
Corneal Ulcers - Pipeline Products Glance 11
Early Stage Products 11
Corneal Ulcers - Products under Development by Companies 12
Corneal Ulcers - Products under Investigation by Universities/Institutes 13
Corneal Ulcers - Companies Involved in Therapeutics Development 14
Amakem NV 14
Digna Biotech, S.L. 15
Lee's Pharmaceutical Holdings Limited 16
Corneal Ulcers - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Target 18
Assessment by Mechanism of Action 20
Assessment by Route of Administration 22
Assessment by Molecule Type 24
Drug Profiles 26
AMA-0526 - Drug Profile 26
Mechanism of Action 26
R&D Progress 26
disitertide - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
LQ-7 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
P-17 - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Small Molecules for Parasitic Corneal Ulcers - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
ZK-003 - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Corneal Ulcers - Recent Pipeline Updates 35
Corneal Ulcers - Dormant Projects 36
Corneal Ulcers - Discontinued Products 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 38
Disclaimer 39

List of Tables

Number of Products under Development for Corneal Ulcers, H2 2015 7
Number of Products under Development for Corneal Ulcers - Comparative Analysis, H2 2015 8
Number of Products under Development by Companies, H2 2015 9
Number of Products under Investigation by Universities/Institutes, H2 2015 10
Comparative Analysis by Early Stage Products, H2 2015 11
Products under Development by Companies, H2 2015 12
Products under Investigation by Universities/Institutes, H2 2015 13
Corneal Ulcers - Pipeline by Amakem NV, H2 2015 14
Corneal Ulcers - Pipeline by Digna Biotech, S.L., H2 2015 15
Corneal Ulcers - Pipeline by Lee's Pharmaceutical Holdings Limited, H2 2015 16
Assessment by Monotherapy Products, H2 2015 17
Number of Products by Stage and Target, H2 2015 19
Number of Products by Stage and Mechanism of Action, H2 2015 21
Number of Products by Stage and Route of Administration, H2 2015 23
Number of Products by Stage and Molecule Type, H2 2015 25
Corneal Ulcers Therapeutics - Recent Pipeline Updates, H2 2015 35
Corneal Ulcers - Dormant Projects, H2 2015 36
Corneal Ulcers - Discontinued Products, H2 2015 37

List of Figures

Number of Products under Development for Corneal Ulcers, H2 2015 7
Number of Products under Development for Corneal Ulcers - Comparative Analysis, H2 2015 8
Number of Products under Development by Companies, H2 2015 9
Comparative Analysis by Early Stage Products, H2 2015 11
Assessment by Monotherapy Products, H2 2015 17
Number of Products by Targets, H2 2015 18
Number of Products by Stage and Targets, H2 2015 18
Number of Products by Mechanism of Actions, H2 2015 20
Number of Products by Stage and Mechanism of Actions, H2 2015 20
Number of Products by Routes of Administration, H2 2015 22
Number of Products by Stage and Routes of Administration, H2 2015 22
Number of Products by Molecule Types, H2 2015 24
Number of Products by Stage and Molecule Types, H2 2015 24
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Siemens Adds To the Growth of Wind Power Generation Market
    Siemens has been presenting ground-breaking strategies and pioneering solutions for energy generation for an intelligent power supply globally. With an expansive portfolio and wide-ranging proficiency in wind power generation, Siemens is likely to aid in increasing the share of wind power in the US energy mix. With New Mexico’s vicinity to significant wind energy areas, [...]
  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Current State of Blood Banking Market, Products, Technologies and Services
    The global blood banking and blood products market is expected to reach US$41.9 billion by 2020 with USA continuing to be the largest market worldwide. Asia-Pacific follows a close second with a projected CAGR of 9.1% during this period owing to the refining healthcare infrastructure and increase in the per capita healthcare expenditure. The major [...]
  • United States Dry Eye Syndrome Drugs Sales Market Report 2021
    Published: 22-Aug-2016        Price: US 3800 Onwards        Pages: 120
    This report studies sales (consumption) of Dry Eye Syndrome Drugs in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Allergan - Novartis - Santen - Shire - Otsuka - Eyegate Pharma - Can-Fite BioPharma Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into - Antibiotic drops - Hormone drops ......
  • Global Vision Care Product Market Research Report 2021
    Published: 17-Aug-2016        Price: US 2900 Onwards        Pages: 102
    Notes: Production, means the output of Vision Care Product Revenue, means the sales value of Vision Care Product This report studies Vision Care Product in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Novartis - Bausch + Lomb - Essilor - Hoya - Luxottica......
  • 2016 Carteolol Industry Market Report
    Published: 17-Aug-2016        Price: US 2800 Onwards        Pages: 150
    The 'Global and Chinese Carteolol Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Carteolol industry with a focus on the Chinese market. The report provides key statistics on the market status of the Carteolol manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications......
  • Global Dry Eye Syndrome Drugs Sales Market Report 2021
    Published: 03-Aug-2016        Price: US 4000 Onwards        Pages: 129
    This report studies sales (consumption) of Dry Eye Syndrome Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Allergan Novartis Santen Shire Otsuka Eyegate Pharma Can-Fite BioPharma Market Segment by Regions, this report splits......
  • Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period
    Published: 01-Aug-2016        Price: US 4995 Onwards        Pages: 150
    Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period Summary Ophthalmology is a therapy area that deals with the diagnosis, treatment and prevention of diseases associated with the eyes and visual system. Most eye disorders occur over a long period of time, and are initially asymptomatic or cause only a slight decrease in vision. However, over time this becomes quite marked. Ophtha......
  • Diabetic Macular Edema - Pipeline Review, H2 2016
    Published: 20-Jul-2016        Price: US 2000 Onwards        Pages: 195
    Global Markets Direct's, ‘Diabetic Macular Edema - Pipeline Review, H2 2016', provides an overview of the Diabetic Macular Edema pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diabetic Macular Edema, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its ......
  • Global and China Contact Lens Solution Sales Market Report 2020
    Published: 07-Jul-2016        Price: US 2900 Onwards        Pages: 122
    This report studies Contact Lens Solution in Global and China market, focuses on top manufacturers in global and China market, involving Contact Lens Solution price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Contact Lens Solution in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011. Split by product types, with production, revenue, market share and price ......
  • United States Keratoconjunctivitis Sicca Drugs Industry 2016 Market Research Report
    Published: 06-Jul-2016        Price: US 3800 Onwards        Pages: 131
    The United States Keratoconjunctivitis Sicca Drugs Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Keratoconjunctivitis Sicca Drugs industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Keratoconjunctivitis Sicca Drugs market analysis is provided for the United States markets including development trends, competitive landscape analys......
  • Global Ophthalmics Partnering 2010-2016: Deal trends, players and financials
    Published: 01-Jul-2016        Price: US 2995 Onwards        Pages: 500
    "Delivery of this report will take 1-3 days after purchase." Summary The Global Ophthalmics Partnering 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access t- the ophthalmics partnering deals and agreements entered int- by the worlds leading healthcare companies Global Ophthalmics Partnering 2010 t- 2016 provides the full collection of Ophthalmics disease deals signed between the w......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs